Avoro Capital Advisors LLC Takes Position in Celcuity, Inc. $CELC

Avoro Capital Advisors LLC acquired a new stake in shares of Celcuity, Inc. (NASDAQ:CELC) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,111,111 shares of the company’s stock, valued at approximately $310,302,000. Celcuity comprises 3.0% of Avoro Capital Advisors LLC’s holdings, making the stock its 11th largest holding. Avoro Capital Advisors LLC owned 0.07% of Celcuity as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of CELC. EverSource Wealth Advisors LLC raised its position in shares of Celcuity by 1,329.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 343 shares of the company’s stock valued at $34,000 after buying an additional 319 shares during the last quarter. US Bancorp DE raised its position in shares of Celcuity by 25.4% during the third quarter. US Bancorp DE now owns 706 shares of the company’s stock valued at $35,000 after buying an additional 143 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of Celcuity by 78.9% during the second quarter. BNP Paribas Financial Markets now owns 2,647 shares of the company’s stock valued at $35,000 after buying an additional 1,167 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Celcuity during the fourth quarter valued at approximately $42,000. Finally, Ogorek Anthony Joseph NY ADV raised its position in shares of Celcuity by 19.7% during the fourth quarter. Ogorek Anthony Joseph NY ADV now owns 662 shares of the company’s stock valued at $66,000 after buying an additional 109 shares during the last quarter. Institutional investors own 63.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CELC. Wall Street Zen cut shares of Celcuity from a “hold” rating to a “sell” rating in a research report on Saturday, April 25th. Craig Hallum reduced their price target on shares of Celcuity from $189.00 to $171.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Macquarie Infrastructure set a $160.00 price target on shares of Celcuity in a research report on Thursday, May 28th. Needham & Company LLC restated a “buy” rating and issued a $157.00 price target on shares of Celcuity in a research report on Friday, May 15th. Finally, Citigroup restated a “market outperform” rating on shares of Celcuity in a research report on Thursday, May 28th. Eleven research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $152.09.

Insider Buying and Selling at Celcuity

In other news, Director Richard E. Buller sold 9,000 shares of the business’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the completion of the sale, the director directly owned 6,760 shares of the company’s stock, valued at approximately $949,509.60. The trade was a 57.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director David Dalvey sold 25,000 shares of the business’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $140.68, for a total transaction of $3,517,000.00. Following the sale, the director directly owned 65,000 shares of the company’s stock, valued at $9,144,200. This represents a 27.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,000 shares of company stock valued at $5,111,950 over the last ninety days. 13.33% of the stock is owned by insiders.

Celcuity Stock Down 1.0%

NASDAQ CELC opened at $87.32 on Wednesday. The company has a quick ratio of 12.31, a current ratio of 12.31 and a debt-to-equity ratio of 6.04. The company has a fifty day moving average of $118.82 and a two-hundred day moving average of $111.13. The firm has a market capitalization of $4.26 billion, a price-to-earnings ratio of -22.39 and a beta of 0.10. Celcuity, Inc. has a 52 week low of $11.27 and a 52 week high of $151.02.

Celcuity (NASDAQ:CELC) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.97) EPS for the quarter, topping the consensus estimate of ($1.07) by $0.10. On average, analysts predict that Celcuity, Inc. will post -3.69 earnings per share for the current year.

Celcuity Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.